Bruce W. Levins
President chez Omega Laboratories Ltd.
Profil
Bruce W.
Levins is currently the Vice President-Operations at Sandoz Canada, Inc. and the President & General Manager at Omega Laboratories Ltd.
He obtained an undergraduate degree from Toronto Metropolitan University.
Postes actifs de Bruce W. Levins
| Sociétés | Poste | Début |
|---|---|---|
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Directeur des opérations | - |
Omega Laboratories Ltd.
 Omega Laboratories Ltd. Pharmaceuticals: OtherHealth Technology Part of Juno Pharmaceuticals Corp., Omega Laboratories Ltd. engages in the development, production, marketing, and distribution of medical injection and non-injection products. The company is based in Montréal, Canada. The Canadian company was founded in 1958. Omega Laboratories was acquired by Juno Pharmaceuticals Corp. from Ellimist Singapore Pte Ltd. on May 15, 2023. | President | - |
Formation de Bruce W. Levins
| Toronto Metropolitan University of | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
Omega Laboratories Ltd.
Omega Laboratories Ltd. Pharmaceuticals: OtherHealth Technology Part of Juno Pharmaceuticals Corp., Omega Laboratories Ltd. engages in the development, production, marketing, and distribution of medical injection and non-injection products. The company is based in Montréal, Canada. The Canadian company was founded in 1958. Omega Laboratories was acquired by Juno Pharmaceuticals Corp. from Ellimist Singapore Pte Ltd. on May 15, 2023. | Health Technology |
